Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 Adjuvant Therapy for Early Mild COVID-19
NCT05008003Unknown
- Sponsor
- Ayub Teaching Hospital
- Start
- Sep 2022
- Primary completion
- Mar 2023
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, open-label trial of vitamin d in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Ayub Teaching Hospital. Primary endpoints: SARS-CoV-2 Negativity by RT-PCR at 14 days and COVID-19 symptoms improvement at 14 days. Status: unknown.
02
Drugs
vitamin d
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05008003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05008003.